financetom
Business
financetom
/
Business
/
Accenture Invests in Workhelix to Support AI Training for Employees
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Accenture Invests in Workhelix to Support AI Training for Employees
Feb 27, 2025 10:09 AM

12:46 PM EST, 02/27/2025 (MT Newswires) -- Accenture ( ACN ) invested in Workhelix, a tech services company that helps businesses train employees for artificial intelligence.

Workhelix solutions will be integrated into the Accenture LearnVantage platform, which provides training services in areas such as AI and data.

The combination also "will help organizations identify specific tasks and roles that can be streamlined or optimized with generative AI and create detailed, actionable roadmaps that track results against target goals," Accenture ( ACN ) said Thursday in a statement.

Terms of the investment weren't disclosed.

Price: 360.05, Change: +1.70, Percent Change: +0.47

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
European firms, banks must boost investment in critical minerals, official says
European firms, banks must boost investment in critical minerals, official says
Apr 22, 2024
LONDON, April 22 (Reuters) - European firms such as automakers and financial institutions need to step up investment in critical minerals for the region to develop domestic sources of the key raw materials for the energy transition, the head of an EU-funded organisation said. The European Union has launched an ambitious roadmap to accelerate production of minerals such as lithium...
Bristol Myers signs $380 mln CAR-T therapies supply deal with Cellares
Bristol Myers signs $380 mln CAR-T therapies supply deal with Cellares
Apr 22, 2024
April 22 (Reuters) - Drugmaker Bristol Myers Squibb said it has signed a $380 million deal with contract manufacturer Cellares to manufacture its CAR-T cell therapies in the United States, EU and Japan. The collaboration will help Bristol Myers to expand its manufacturing capacity due to increasing demand. The company said in February it was looking to launch both its...
Joint Stock Company Kaspi.kz's Q1 Net Income, Revenue Rise
Joint Stock Company Kaspi.kz's Q1 Net Income, Revenue Rise
Apr 22, 2024
07:43 AM EDT, 04/22/2024 (MT Newswires) -- Joint Stock Company Kaspi.kz (KSPI) reported Q1 net income Monday of 223.44 billion Kazakhstani tenge ($500 million), up from 174.21 billion tenge a year earlier. Two analysts polled by Capital IQ expected 220.42 billion tenge. Revenue for the quarter ended March 31 was 552.81 billion tenge, up from 395 billion tenge a year...
Top Premarket Gainers
Top Premarket Gainers
Apr 22, 2024
07:42 AM EDT, 04/22/2024 (MT Newswires) -- Moolec Science ( MLEC ) shares more than doubled Monday premarket after the company said it secured US Department of Agriculture approval for its genetically engineered soybean Piggy Sooy. Gryphon Digital Mining ( GRYP ) shares surged 18% following a 2.2% drop in the previous session. AMTD IDEA Group ( AMTD ) shares...
Copyright 2023-2026 - www.financetom.com All Rights Reserved